News

New Members Appointed to CADTH Expert Committees

Dr. Brian O’Rourke, CADTH President and Chief Executive Officer, is pleased to announce the appointment of four new members and a new chair to Canadian Drug Expert Committee (CDEC), and two new members and a new chair to its Health Technology Expert Review Panel (HTERP).

Canadian Drug Expert Committee

Dr. James Silvius, Associate Professor in the Division of Geriatric Medicine at the University of Calgary’s Cumming School of Medicine, becomes Chair of CDEC for a two-year term. Dr. Silvius brings to the role significant understanding of drug evaluation and pharmaceutical management across the continuum of care.

In addition, the following individuals have been appointed as members of CDEC:

  • Dr. Allan Grill, Assistant Professor in the Department of Family and Community Medicine at the University of Toronto, and Lead Physician at the Markham Family Health Team (Three-year term).
  • Dr. Alun Edwards, Professor of Medicine at the Cumming School of Medicine, University of Calgary, and a clinical endocrinologist (Three-year term).
  • Dr. Ran Goldman, Professor of Pediatrics at the University of British Columbia, a clinician-investigator and pediatrician, with a fellowship in pediatric emergency medicine and clinical pharmacology and toxicology (Two-year term).
  • Bob Gagne holds a Master of Business Administration from York University and a Bachelor of Science from Western University (Two-year term).

Health Technology Expert Review Panel

Dr. Hilary Jaeger, a former Surgeon General of the Canadian Armed Forces and National Medical Officer of Veterans Affairs Canada, becomes Chair of HTERP for a two-year term. Over the course of her distinguished career, Dr. Jaeger has played a key role in supporting and promoting health care evidence-based practices.

In addition, the following individuals have been appointed as members of HTERP for two-year terms:

  • Dr. Jean-Eric Tarride, Associate Professor at McMaster University in the Department of Health Research Methods, Evidence, and Impact, and the Department of Economics.
  • Dr. Lynette Reid, Associate Professor in the Department of Bioethics, Faculty of Medicine at Dalhousie University.

Biographies of CDEC  and HTERP members are available on the CADTH website.

Dr. O’Rourke would like to thank the following CDEC and HTERP members who concluded their terms of office: Dr. Lindsay Nicolle (CDEC Chair), Mr. Frank Gavin (CDEC public member), Dr. Harindra Wijeysundera (CDEC Member), Dr. Irvin Mayers (CDEC Member), Dr. Stirling Bryan (HTERP Chair), and Dr. Lisa Schwartz (HTERP Member).

The Role of CADTH Expert Committees

The CDEC and HTERP committees provide expert advice and recommendations to CADTH. Members are selected from across Canada, based on their clinical and policy expertise relating to the assessment of health technologies.

CDEC

CDEC is an appointed, pan-Canadian advisory body composed of individuals with expertise in drug therapy, drug evaluation, and drug utilization as well as public members (for a lay perspective). As part of the CADTH Common Drug Review process, CDEC makes recommendations to each of the participating federal, provincial, and territorial publicly funded drug plans regarding reimbursements on their formularies. It also makes recommendations related to the identification, evaluation, and promotion of optimal drug prescribing and use in Canada.

HTERP

HTERP is an advisory body convened to develop guidance and/or recommendations on non-drug health technologies. The panel provides advice and non-binding recommendations to help decision-makers across Canada make informed decisions about the best use of non-pharmaceutical health technologies such as medical devices, surgical procedures, diagnostic tests, and other non-pharmaceutical interventions.